




3DepartmeComparison of Early and Midterm Results
of Open and Endovascular Treatment of
Popliteal Artery AneurysmsRaffaele Pulli,1 Walter Dorigo,1 Aaron Fargion,1 Giovanni Pratesi,2
Alessandro Alessi Innocenti,1 Domenico Angiletta,3 and Carlo Pratesi,1 Florence, Rome, and
Bari, ItalyBackground: Aim of this study was to retrospectively compare perioperative (<30 days) and 2-
year results of open and endovascular management of popliteal artery aneurysms (PAAs) in
a single-center experience.
Methods: From January 2005 to December 2010, 64 PAAs in 59 consecutive patients were oper-
ated on at our institution; in 43 cases, open repair was performed (group 1), whereas the remaining
21 cases had an endovascular procedure (group 2). Data from all the interventions were prospec-
tively collected in a dedicated database, which included main preoperative, intraoperative, and
postoperative parameters. Early results in terms of mortality, graft thrombosis, and amputation
rates were analyzed and compared by c2 text or Fisher exact text. The surveillance program con-
sisted of clinical and ultrasonographic examinations at 1, 6, and 12 months and yearly thereafter.
Follow-up results (survival, primary and secondary patency, limb salvage) were analyzed by
KaplaneMeier curves, and differences in the two groups were assessed by log-rank test.
Results: There were no differences between the two groups in terms of sex, age, risk factors
for atherosclerosis, and comorbidities; PAAs were symptomatic in 48% of cases in group 1 and
in 29% in group 2 (P ¼ 0.1). Fifteen patients with mild-to-moderate acute ischemia due to PAA
thrombosis underwent preoperative intra-arterial thrombolysis, 13 in group 1 and 2 in group 2. In
open surgery group, nine cases were treated with aneurysmectomy and prosthetic graft interpo-
sition, and in seven cases, the aneurysm was opened and a prosthetic graft was placed inside
the aneurysm. In 27 cases, ligation of the aneurysm with bypass grafting (21 prosthetic grafts
and 6 autologous veins) was carried out. In group 2, 20 patients had endoprosthesis placement,
whereas in the remaining patient, a multilayer nitinol stent was used. There was one perioper-
ative death in a patient of group 2 who underwent concomitant endovascular aneurysm repair
and PAA endografting. Cumulative 30-day death and amputation rate was 4.5% in group 1
and 4.7% in group 2 (P ¼ 0.9). Follow-up was available in 61 interventions (96%) with
a mean follow-up period of 22.5 months (range: 1e60). Estimated primary patency rates at
24 months were 78.1% in group 1 and 59.4% in group 2 (P ¼ 0.1). Freedom from reintervention
rates at 24 months were 79% in group 1 and 61.5% in group 2 (P ¼ 0.2); estimated 24-month
secondary patency rates were 81.6% in group 1 and 78.4% in group 2 (P ¼ 0.9), and freedom
from amputation rates were 92.7% and 95%, respectively (P ¼ 0.7).
Conclusions: Endovascular treatment of PAAs provided, in our initial experience, satisfactory
perioperative and 1-year results, not significantly different from those obtained with prostheticnt of Vascular Surgery, University of Florence, Florence,
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2 Pulli et al. Annals of Vascular Surgeryopen repair in patients with similar clinical and anatomical status. There is, however, a trend
toward poorer primary patency rates among patients endovascularly treated, who also seem
to require more frequently a reintervention.INTRODUCTION
Popliteal artery is the second most frequent localiza-
tion of arterial aneurysms.1e3Main complications of
popliteal artery aneurysm (PAA) include rupture,
distal embolization, and thrombosis, leading to
high risk of limb loss.4,5 For this reason, elective
surgical management of asymptomatic aneurysms
larger than 20 mm has been advocated by several
authors.6,7
Results of open repair of PAAs are good, particu-
larly in the elective setting, with high rates of graft
patency and freedom from amputation during
follow-up.8e10
In recent years, in the era of large spreading of
endovascular treatment in different vascular fields,
PAA exclusion with stentegraft has been emerging
as a possible alternative to open surgery, particularly
in high-risk patients.11
Also in our institution, after the long and large
experience in open repair of PAAs,10 in recent years,
we are getting used to performing endovascular
approach in selected patients.
The aim of this study was to retrospectively
compare perioperative (<30 days) and 2-year
results of open and endovascular management of
PAAs in our experience.MATERIALS AND METHODS
From January 2005 to December 2010, 64 PAAs in
59 consecutive patients were operated on at our
institution; in 43 cases, a conventional open repair
was performed (group 1), whereas the remaining
21 cases had an endovascular procedure (group 2).
The temporal trend of interventions is shown in
Figure 1. Data from all the interventions were
prospectively collected in a dedicated database,
which included demographic data, preoperative
risk factors, clinical and diagnostic assessment,
intraoperative features, and early and follow-up
outcomes.Preoperative Assessment, Indications for
the Treatment, and Technical DetailsAll patients underwent duplex examination and
angio-computed tomography scan or digital
subtraction angiography before surgery. Our indica-
tion for treating asymptomatic aneurysm wasa diameter of >20 mm. In symptomatic patients,
indication for surgery was unrelated to aneurysms’
diameter.
At the beginning of our experience, our indica-
tions for endovascular repair were the presence of
a focal PAA, limited to popliteal fossa, with diame-
ters of vessels compatible with commercially avail-
able stentegrafts, and at least two patent tibial
vessels.
In the following years, we adopted more liberal
indications, and nowadays, we evaluate for endo-
vascular feasibility of also longer lesions, involving
the entire popliteal artery from the adductor tendon
to the popliteal bifurcation, provided that a proximal
and distal landing zone of at least 2 cm length is
present, with the patency of at least one tibial vessel.
Endografts were oversized 10% to 15% relative to
the landing zones. When more than one endograft
was required for exclusion, overlap of at least 2 cm
to prevent a type III endoleak from component sepa-
ration was used. Overlapping endografts differed by
no more than 2 mm in diameter. In the presence of
incomplete proximal sealing of endograft at comple-
tion angiography, adjunctive ballooning and, when
necessary, stenting was performed. All endovascu-
lar procedures were carried out in the operating
room.Management in Patients With Acute
IschemiaIn selected patients withmild-to-moderate ischemia
(grade I or IIa according to Rutherford’s classifica-
tion of acute ischemia) due to acute aneurysms’
thrombosis, preoperative catheter-directed throm-
bolysis with urokinase (Urochinasi Crinos; Crinos
SPA, Milan, Italy) was performed.
Thrombolytic treatment was administered in
a bolus of 100,000 IU, followed by continuous infu-
sion with a delivery rate of 70,000 IU/hr. In all the
patients, 1,000 to 1,500 IU/hr of sodium heparin
were administered through the same catheter to
maintain values of activated partial thromboplastin
time two times higher than normal value.
Angiographic controls were performed daily or
more, when necessary, and lytic infusion lasted
until patency of popliteal and tibial vessels was
achieved or for a maximum of 3 days when unsuc-
cessful. Thrombolysis was defined successful in the




Endovascular 2 1 2 3 8 5
Open surgery 10 6 8 11 5 3
2005 2006 2007 2008 2009 2010
Fig. 1. Temporal trend in open and endovascular popli-
teal artery aneurysm repair in the present series.
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was performed within 24 hours from the cessation
of administration of thrombolytic treatment. In the
case of unsuccessful thrombolysis, a prompt surgical
attempt was performed.Follow-upThe surveillance program consisted of clinical and
ultrasonographic examinations at 1, 6, and 12
months and yearly thereafter. Patency of the graft
and status of anastomoses, inflow and outflow
vessels, and contralateral femoropopliteal axis
were assessed. In patients undergoing endovascular
treatment, exclusion of aneurysmal sac from the
blood flow was also examined.
All studies were performed using an Acuson
Sequoia 512 ultrasound system (Acuson Corpora-
tion, Mountain View, CA).Definition of the OutcomesPrimary patency was defined as uninterrupted
patency without procedures performed on or at
the margin of the treated segment, whereas
secondary patency was defined as restored patency
through the original treated segment. Freedom
from amputation was defined as the avoidance of
above- or below-knee amputation, whereas
freedom from reinterventions was defined as the
avoidance of any open or endovascular new proce-
dure on the treated artery.StatisticsEarly results in terms of mortality, graft thrombosis,
and amputation rates were analyzed and compared
by c2 text or Fisher exact text. Multivariate analysis
(stepwise logistic regression analysis) for 30-day
thrombosis was performed for the factors that
were significant at univariate analysis.
Follow-up results (survival, primary and
secondary patency, freedom from amputation,
freedom from reintervention) were analyzed byKaplaneMeier curves, and differences in the two
groups were assessed by log-rank test. Univariate
and multivariate analyses (Cox regression) of the
factors affecting primary patency in both groups
were performed. In Cox regression analysis, the
factors with statistical significance at univariate
analysis were included. Statistical significance was
defined as a P value of <0.05.
Statistical analysiswasperformedwithadedicated
software for Windows (SSPS 18 Inc., Chicago, IL).RESULTSDemographic Data, Clinical Status, and
Anatomical StatusThere were no differences between the two groups
in terms of sex, age, risk factors for atherosclerosis,
and comorbidities, except for a significantly higher
percentage of arterial hypertension in group 2
than in group 1 (Table I).
In 22 cases, contralateral PAA was present (13 in
group 1 and 9 in group 2). Other aneurysms were
present in 22 cases (34.5%), 14 in group 1
(32.5%) and 8 in group 2 (42%), without significant
differences between the two group; in 20 cases (12
in group 1 and 8 in group 2), the aneurysm was
located at aortoiliac level, whereas in the remaining
two patients, a contralateral common femoral artery
aneurysm and a splenic artery were present.
Nine patients (three in group 1 and six in group 2)
had been previously operated on for abdominal
aortic aneurysm.
Clinical features were similar in the two groups,
even in the presence of a trend toward a higher
percentage of symptomatic patients in group 1,
and are reported in Table I; also, the status of runoff
was similar between the two groups, but, again,
there was a trend toward a higher percentage of
patients with a runoff score of <2 in group 1 (19
cases, 44%) than in group 2 (4 cases, 20%; P ¼
0.06, odds ratio [OR]: 0.29, 95% confidence interval
[CI]: 0.08e1.1). Mean diameter of the treated lesion
was 34.7 mm in group 1 and 35.6 mm in group 2
(P ¼ 0.9, 95% CI: 7.2/5.5).Acute Ischemia and RuptureFifteen patients with mild-to-moderate acute
ischemia due to PAA thrombosis underwent preop-
erative intra-arterial thrombolysis, 13 in group 1
(30.2%) and 2 in group 2 (9.5%; P ¼ 0.07, OR:
0.2, 95% CI: 0.04e1.1; Fig. 2). The mean duration
of thrombolytic treatment was significantly longer
in group 1 (26.8 hours, SE: 7.8) than in group 2
Table I. Demographic data and clinical presentation in groups 1 and 2
Demographic and clinical data Group 1 (43 cases) Group 2 (18 cases) P OR and 95%CI
Mean age 73.4 74 0.6
Females 2 (4.5%) 0 0.3
Smoker or past smoker 35 (81%) 15 (71%) 0.5
Coronary artery disease 16 (37%) 6 (28.5%) 0.5
Hyperlipidemia 13 (30%) 6 (28.5%) 0.9
Diabetes 4 (10%) 2 (10%) 0.9
Arterial hypertension 34 (79%) 20 (95%) 0.05
Asymptomatic 22 (52%) 15 (71%) 0.1 0.4, 0.2e1.2
Symptomatic 21 (48%) 6 (29%)
Claudication 6 (14%) 2 (9.5%)
Acute ischemia 14 (32%) 3 (14%)
Rupture e 1 (5.5%)
Chronic ischemia 1 (2%) e
4 Pulli et al. Annals of Vascular Surgery(9.9 hours, SE: 8.4, P ¼ 0.04). Thrombolysis was
successful in 8 of the 13 patients in group 1 and in
one patient of group 2. The remaining patient of
group 2 had complete recanalization of PAA but
only partial recanalization of tibial vessels.
Twomajor complications occurred during throm-
bolysis, both in group 1done patient developed
a severe (<50,000) thrombocytopenia, requiring
the cessation of thrombolytic drug and of heparin,
whereas the other patient suffered from a contralat-
eral femoral pseudoaneurysm, requiring surgical
repair during the same intervention for the treat-
ment of the PAA.
In one case of a patient with known PAA present-
ing with severe pain of the affected leg, a contained
rupture of a large (5  6 cm) PAA was present at
preoperative computed tomography scan, and this
case was treated with an endovascular procedure.12Operative DetailsIn open surgery group, nine cases were treated with
aneurysmectomy and prosthetic interposition,
whereas in seven cases, the aneurysm was opened
and a prosthetic graft was placed inside the aneu-
rysm in amanner similar to that used to repair aortic
aneurysms. In 27 cases, proximal and distal ligation
of the aneurysm with bypass grafting (21 with pros-
thetic graft and 6 with autologous vein) was carried
out. A medial approach was used in 39 cases
(90.5%) and a posterior approach was used in 4
cases. In 36 interventions, the inflow vessels were
the common or superficial femoral artery, and in
the remaining 7, it was the above-knee popliteal
artery. The outflow vessel was in most cases the
below-knee popliteal artery (37 cases, 86%), and
in 6 cases, it was the tibioperoneal trunk or a tibial
vessel. Intraoperative stop-flow thrombolysis13,14was used in four patients. Associated interventions
at distal anastomotic site were performed in nine
cases (vein cuff in four cases, patching in two cases,
and arteriovenous fistula in the remaining three),
whereas two patients had common-to-deep femoral
artery short bypass for concomitant involvement of
common or deep femoral arteries.
In this group, all the patients had intraoperative
administration of 30 IU/kg of intravenous heparin
at arterial clamping.
Postoperative and long-term medical treatment
consisted of single antiplatelet therapy in 2 cases,
double antiplatelet therapy in 28 cases, and oral
anticoagulation therapy in 13 patients, the regimen
for anticoagulation or antiplatelet being determined
just on the basis of distal perfusion.
In group 2, 20 patients had endoprosthesis place-
ment (Hemobahn or Viabahn, W.L. Gore & Associ-
ates Inc, Flagstaff, AZ); in the remaining patient,
a multilayer nitinol stent was used (Cardiatis Multi-
layer 3D Stent; Cardiatis SA, Isnes, Belgium).
In 14 cases, ipsilateral surgical femoral approach
was used, whereas 7 patients had ipsilateral percuta-
neous access. Inflow vessels were superficial
femoral artery in 15 cases and proximal popliteal
artery in 6 cases; the outflow vessel was in all but
one case the below-knee popliteal artery, whereas
in the remaining patient, it was the tibioperoneal
trunk.
The mean number of placed stents was 2 (range:
1e5), with a mean length of 220 mm (range: 100e
350). The mean number of stents significantly
increased in the period 2008 to 2010 with respect
to 2005 to 2007 (1.4 and 2.4; P ¼ 0.05, 95%
CI: 1.9/0.008), whereas there were no signifi-
cant differences in terms of the mean length of arte-
rial coverage (185 mm and 250 mm; P ¼ 0.1, 95%
CI: 160.1/31.5). Associated proximal stenting
Fig. 2. Thrombosed popliteal artery aneurysm treated with thrombolysis and endovascular repair: (A) preoperative angi-
ography, (B) completion angiographyafter successful thrombolysis, (C) and (D) final result after theplacement of endograft.
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proximal sealing.
All the patients of group 2 had intravenous
administration of 5000 IU of sodium heparin at the
beginning of the procedure. Postoperative and
long-term medical treatment consisted of double
antiplatelet therapy in all the cases.Perioperative (<30 Days) ResultsTechnical success occurred in all the patients of
group 2. Early results are listed in Table II.
There was one perioperative death in a patient of
group 2 who underwent concomitant endovascular
aneurysm repair and PAA endografting. On postop-
erative day 1, the patient developed an acute throm-
bosis of popliteal endografting, which required
conversion to below-knee femoropopliteal bypass,
followed by major amputation due to graft occlu-
sion. During postoperative course in intensive care
unit, the patient suffered from a fatal acute myocar-
dial infarction. At 30 days, two thromboses occurred
in group 1done case was successfully treated with
thrombolysis and stenting of distal anastomosis,
whereas the other case lead to major amputation,despite a new surgical attempt; in group 2, two
thromboseswere recorded, both successfully treated
with thrombolysis, one case with adjunctive distal
stenting. Another below-knee amputation was per-
formed in a patient of group 1 treated for acute PAA
thrombosis who developed an irreversible ischemia
of the foot, despite the good patency of surgical
revascularization. Both the amputations in group 1
occurred in patients operated on for acute ischemia.
Cumulative 30-day death and amputation rate
was 4.5% in group 1 and 4.7% in group 2 (P ¼
0.9, OR: 1.02, 95% CI: 0.08e11.9).
Other early reinterventions were required in
both groups; in group 1, one patient suffered from
an acute bleeding from the distal anastomosis,
requiring surgical revision. In group 2, one patient
developed postoperative bleeding at the site of arte-
rial catheterization and underwent surgical repair of
common femoral artery lesion.
As a consequence, there was a trend toward
a higher percentage of reinterventions in group 2
than in group1 (P¼0.06,OR: 2.1, 95%CI: 0.6e6.6).
At univariate analysis for the risk of perioperative
thrombosis in thewhole group, the presence of acute
ischemia (P¼ 0.03, OR: 1.2, 95%CI: 0.9-1.8) and of






Death e 1 (4.7%) 0.1
Thrombosis 2 (4.5%) 3 (14.2%) 0.2
Amputation 2 (4.5%) 1 (4.7%) 0.9
Reintervention 2 (4.5%) 4 (19%) 0.06
30-day death and
amputation rate
2 (4.5%) 1 (4.7%)a 0.9
aAmputation and death in the same patient.
6 Pulli et al. Annals of Vascular Surgerydiabetes (P¼ 0.005, OR: 1.5, 95%CI: 0.8e2.5) were
found to significantly affect the outcome; there was
also a trend toward poorer patency rates in patients
with coronary artery disease (P ¼ 0.07, OR: 1.1,
95%CI: 0.9e1.4). Atmultivariate analysis, only dia-
beteswas found to be associatedwith poorer patency
rates at 30 days (P¼ 0.04,OR: 0.7, 95%CI: 0.4e1.1).Follow-up ResultsFollow-up was available in 61 interventions
(96.5%) with a mean follow-up period of 22.5
months (range: 1e60). In this period, there were
no new deaths, whereas 1 amputation and 11 graft
thrombosis occurred. Mean duration of follow-up
was similar between the two groups (23.5 months
and 20.5 months, respectively; P ¼ 0.9, 95%
CI: 6.6/12.2).
Estimated primary patency rates at 24 months
were 78.1% in group 1 and 59.4% in group 2 (P ¼
0.2, log-rank: 1.7, 95% CI: 0.7e7.4; Fig. 3). Seven
thromboses occurred in group 1din three cases,
thrombolysis followed by percutaneous transluminal
angioplasty of distal anastomosis (in two cases with
stenting) was performed. Three patients had graft
thrombosis without critical ischemia and were medi-
callymanaged, whereas in the remaining case, major
amputation was necessary. In group 2, there were
four late thrombosesdtwo cases were managed
with thrombolysis followed, in one case, by stenting
of the proximal part of the endograft. In one case,
conversion to below-knee bypass was necessary,
whereas the remaining patient had graft thrombosis
without critical ischemia and was medically
managed. Recurrent thrombosis occurred in two
patients, one in each group, leading to intermittent
claudication, and itwasmedicallymanaged. Freedom
from reintervention rates at 24 months were 79% in
group 1 and 61.5% in group 2 (P¼ 0.2, log-rank: 1.6,
95% CI: 0.6e7.3); estimated 24-month secondary
patency rates were 81.6% in group 1 and 78.4% in
group 2 (P ¼ 0.9, log-rank: 0.04, 95% CI: 0.1e4.7;Fig. 4), whereas freedom from amputation rates
were 92.7% and 95%, respectively (P ¼ 0.7, log-
rank: 0.1, 95% CI: 0.8e7.9).
In one patient in group 2, a type II endoleak from
a large genicular artery was noted at 12 months,
with a slight increase (<5 mm) in sac diameter
with respect to preoperative value, which is still
under surveillance.
Univariate and multivariate analyses for the risk
of graft thrombosis during follow-up in the whole
group demonstrated that only the need for tibial
anastomosis/landing significantly affected that
outcome (Table III). The same separate analysis in
the two groups demonstrated that in group 1,
primary patency was significantly affected by the
need of a tibial anastomosis both at univariate and
multivariate analysis (Table IV), whereas in group
2, no factor was found to significantly affect the
outcome (Table V).DISCUSSION
Open surgical repair is a well-established method of
treatment of PAAs, providing excellent results in
several studies with large number of patients and
long-term follow-up data analysis.8e10,15,16 On the
basis of these results and considering the high risk
of severe complications in patients with untreated
aneurysms,17,18 it is nowadays accepted that the
indication for treatment is the presence of asymp-
tomatic aneurysms larger than 20 mm in patients
at low surgical risk.6 Also in symptomatic lesions,
particularly in the presence of limb-threatening
ischemia due to PAA thrombosis or embolization,
results of open surgery, even if poorer than those
obtained in elective situations,19 are still satisfac-
tory,20 provided that an aggressive policy of tibial
salvage, including preoperative and intraoperative
thrombolysis,5 is adopted.
In the past decade, with the introduction and
wide diffusion of endovascular techniques also in
peripheral arterial district and with the develop-
ment of low-profile flexible cover-stents for distal
applications, endovascular repair has been proposed
for the treatment of PAAs, and promising results
have been reported by different authors.21e26
Also, in our institution, where a large experience
on open repair of PAAs, providing excellent early
and long-term results, has been collected and re-
ported in past years,5,10 we have been using endo-
vascular treatment in selected patients with PAAs
since 2005.
The trend of open and endovascular procedures
in this period reflects both the need for taking
Fig. 3. KaplaneMeier curve for primary patency during
follow-up with number of patients at risk and standard
error values at each time interval.
Months 0 12 24
Group 1 (number at risk) 40 29 17
SE 0.03 0.05 0.06
Group 2 (number at risk) 19 8 5
SE 0.07 0.09 0.10
Fig. 4. KaplaneMeier curve for secondary patency
during follow-up with number of patients at risk and
standard error values at each time interval.
Months 0 12 24
Group 1 (number at risk) 40 28 19
SE 0.02 0.06 0.07
Group 2 (number at risk) 19 13 8
SE 0.05 0.08 0.10
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bility tomanage long and complex lesions, requiring
more than one graft and the coverage of a longer
arterial segment, also with more flexible and precise
devices, as demonstrated by the evolution of our
experience.
In this article, we analyzed our early and inter-
mediate results of endovascular treatment of PAAs
and we compared them with those obtained with
open repair in the same period.
A recent meta-analysis25 reported an overall
comparison of the endovascular versus the open
intervention for 43 and 116 patients, respectively.
Antonello et al.27 compared, in a randomized
study, the results of 15 open repairs with those of
15 endovascular procedures performed in asymp-
tomatic PAAs with good runoff status, and they
found no significant differences between the two
options at 12-month follow-up, with some advan-
tages for endovascular repair in terms of operative
time and hospital stay. The same authors updated
their study23 with the analysis of 21 endovascular
procedures compared with 27 open interventionsperformed in asymptomatic PAAs, and they still
found no differences in terms of primary and
secondary patency at 72 months, with a 14% rate
of late conversion to open surgery.
Curi et al.24 retrospectively reviewed their
results in 15 endovascular PAA repairs compared
with 41 open interventions; similar to the previ-
ously cited studies, endovascular treatment was
performed mainly in asymptomatic patients (13
cases, 87%) and all acute PAA thromboses were
treated with open intervention. Estimated 24-
month patency rates were similar between the
two techniques, with 83% and 100% of primary
and secondary patency, respectively, for endovas-
cular treatment.
Stone et al.28 reported seven cases of endovascu-
lar treatment, performed in all but one case in
asymptomatic patients, and 48 open interventions;
even if the study was not appositely designed to
compare the outcomes of the two procedures, two
of the seven endografts thrombosed during follow-
up, whereas graft thrombosis occurred only in two
patients undergoing open repair. However, the
Table IV. Univariate and multivariate (for significant factors at univariate) analyses for primary patency
during follow-up in group 1
Analyzed factors
Univariate analysis Multivariate analysis
Log-rank P 95% CI OR 95% CI OR P
Diabetes 0.7 0.5 0.06e4.5 0.6
PAA thrombosis 0.4 0.6 0.2e2.8 0.7
Symptomatic PAA 0.02 0.6 0.1e2.6 0.5
Limb-threatening ischemia 1.5 0.4 0.1e2.1 0.5
Runoff score 0e1 2.7 0.07 0.8e20.1 4.1
Preoperative thrombolysis 0.05 0.9 0.2e4.3 1
Posterior approach 0.4 0.4 0.05e3.9 0.4
Tibial anastomosis 10.5 0.006 1.7e29.4 7.2 1.1e22.3 4.9 0.03
Prosthetic graft 1.7 0.7 0.08e5.5 0.6
Table III. Univariate and multivariate (for significant factors at univariate) analyses for primary patency
during follow-up
Analyzed factors
Univariate analysis Multivariate analysis
Log-rank P 95% CI OR 95% CI OR P
Diabetes 2.5 0.07 0.08e1.1 0.3
PAA thrombosis 0.2 0.1 0.2e3.6 1.1
Symptomatic PAA 0.5 0.3 0.2e1.7 0.6
Limb-threatening ischemia 1.2 0.5 0.2e2 0.7
Runoff score 0e1 1.3 0.2 0.6e4.9 1.7
Preoperative thrombolysis 0.2 0.5 0.5e5.7 1.4
Endovascular intervention 0.1 0.1 0.7e6.1 2.1
Tibial anastomosis/landing 5.7 0.03 1.1e11.9 3.7 1.3e15.7 4.6 0.01
PAA, popliteal artery aneurysm.
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patency of the graft was significantly higher in
open surgery group.
Results of our series are similar to those reported
by Antonello23 and larger than those reported by
Curi et al.24 and Stone et al.28 in terms of number
of endovascular procedures; moreover, the
percentageof symptomatic PAAs treatedwith endog-
rafting was largely higher (29%), and approximately
one-quarter of the patients of endovascular group
hadonlyonepatentdistal vessel. This fact canexplain
the relatively lower rates of 24-month primary and
secondary patency in our series in comparison with
the previously cited ones and with those reported
in the recent meta-analysis by Cina.25
Although our groups were homogeneous under
a statistical point of view, there was a trend toward
higher percentage of worse patients (symptomatic
with poorer runoff status) in the open group, which
must be taken into account when analyzing our
results.
We did not find any clinical or anatomical factor
affecting immediate and late failure of endovascularprocedure; however, this is probably because of the
relatively small number of patients and events.
The outcome of open repair remains excellent in
our experience, despite the use of prosthetic grafts,
confirming the results of our previous studies,
both in symptomatic and asymptomatic patients.
As previously reported,10 we found the need for
distal tibial anastomosis to significantly affect
follow-up graft patency in this study also, and this
was the only factor associated with an increased
risk of late failure in open repair group.
We did not find significant differences between
the two groups in terms of primary and secondary
patency; however, there was a trend for poorer
primary patency rates in the endovascular group
(possible type I statistical error). One can suppose
that at a longer follow-up period with a larger
number of patients and events, this difference may
become significant, suggesting the need for deeper
and longer analysis.
In acutely thrombosed PAAs, our aggressive
policy of tibial salvage, with the use of intra-
arterial thrombolysis in selected patients with
Table V. Univariate analysis for primary patency during follow-up in group 2
Analyzed factors
Univariate analysis
Log-rank P 95% CI OR
Diabetes 2.9 0.09 0.04e1.3 0.2
PAA thrombosis 0.1 0.6 0.07e5.9 0.6
Symptomatic PAA 0.3 0.7 0.08e5.9 0.6
Limb-threatening ischemia 1.2 0.6 0.06e5.1 0.5
Runoff score 0e1 0.1 0.8 0.09e7.2 0.8
Tibial landing 0.6 0.4 0.04e4.5 0.7
Percutaneous access 0.4 0.5 0.2e18.1 1.9
Adjunctive proximal procedure 1.1 0.2 0.03e2.8 0.2
More than one stent placed 0.2 0.6 0.2e10 1.4
More than 200 mm of stent length 0.5 0.4 0.3e12.5 1.9
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approaching this potentially catastrophic complica-
tion; after the patency of popliteal artery and tibial
vessels is restored, it is now possible to choose
between open and endovascular repair on the basis
of clinical and anatomical consideration; this was
also our strategy, and the two patients who had
thrombolysis followed by endovascular repair had
optimal results, with graft patency and limb salvage
during follow-up.
The rate of both perioperative and late reinter-
ventions was similar between the two groups,
even if we again found a trend toward a higher
risk of early reintervention among patients treated
with endovascular repair. This is a previously unre-
ported finding and should probably be considered
when planning an endovascular procedure, even
though the risk of developing an endoleak is
low in our experience and probably it does not
represent the main complication of endovascular
repair of PAAs.
This study has several limitations. It is a retrospec-
tive nonrandomized study, with a relatively short
period of follow-up, and a low number of events,
making type I statistical error possible both in perio-
perative and follow-up analysis. On the other hand,
in our opinion, the relative homogeneity between
open and endovascular groups in terms of clinical
presentation and runoff status under a statistical
standpoint adds some value to the study, which
well reflects the current daily practice.
In our experience, endovascular repair, in the
presence of a suitable anatomy and with good tibial
runoff, is not only feasible but also safe and with 2-
year results that are clinically acceptable and not
significantly different from open repair. However,
a randomized controlled trial should better define
the true role of endovascular technique in the
management of PAAs.CONCLUSIONS
Endovascular treatment of PAAs provided, in our
initial experience, satisfactory perioperative and
intermediate results, not significantly different
from prosthetic open repair in patients with similar
clinical and anatomical status. There is, however,
a trend toward poorer primary patency rates among
patients endovascularly treated, who also seem to
require more frequently a reintervention. These
findings suggest the need for further analysis at
a longer follow-up with a larger number of patients.REFERENCES
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